Sanofi (SAN.FP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [Euronext FR]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2004 | 12-2003 | 12-2002 | 12-2001 | 12-2000 | |
| Sales | 15,031,705 | 8,033,996 | 7,455,084 | 6,488,000 | 5,963,000 |
| Cost of Goods | 3,750,365 | 1,425,284 | 1,378,948 | 1,253,000 | 1,442,000 |
| Gross Profit | 11,281,340 | 6,608,712 | 6,076,137 | 5,235,000 | 4,521,000 |
| Operating Expenses | 11,586,002 | 3,538,992 | 3,459,281 | 3,129,000 | 2,944,000 |
| Operating Income | -304,662 | 3,069,720 | 2,616,856 | 2,106,000 | 1,577,000 |
| Other Income | -1,537,325 | 58,758 | -109,592 | 34,000 | -17,000 |
| Pre-tax Income | -1,841,987 | 3,128,478 | 2,507,264 | 2,140,000 | 1,560,000 |
| Income Tax | 818,087 | 1,056,060 | 747,128 | 842,000 | 611,000 |
| Net Income Continuous | -3,607,255 | 2,072,418 | 1,760,136 | 1,586,000 | 999,000 |
| Minority Interests | 6,639 | -3,176 | -86,720 | -1,000 | -14,000 |
| Net Income | $-3,607,255 | $2,072,418 | $1,760,136 | $1,585,000 | $985,000 |
| EPS Basic Total Ops | -3.92 | 2.95 | 2.42 | 2.17 | 1.35 |
| EPS Basic Continuous Ops | -3.92 | 2.95 | 2.42 | 2.17 | 1.35 |
| EPS Diluted Total Ops | -3.92 | 2.95 | 2.42 | 2.17 | 1.35 |
| EPS Diluted Continuous Ops | -3.92 | 2.95 | 2.42 | 2.17 | 1.35 |
| EBITDA(a) | $2,211,565 | $3,458,795 | $2,996,138 | $2,407,000 | $1,818,000 |